Welcome to Anagrammer Crossword Genius! Keep reading below to see if efinic is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on efinic.
efinic
Searching in Crosswords ...
The answer EFINIC has 0 possible clue(s) in existing crosswords.
Searching in Word Games ...
The word EFINIC is NOT valid in any word game. (Sorry, you cannot play EFINIC in Scrabble, Words With Friends etc)
There are 6 letters in EFINIC ( C3E1F4I1N1 )
To search all scrabble anagrams of EFINIC, to go: EFINIC
Rearrange the letters in EFINIC and see some winning combinations
5 letters out of EFINIC
Searching in Dictionaries ...
Definitions of efinic in various dictionaries:
No definitions found
Word Research / Anagrams and more ...
Keep reading for additional results and analysis below.
| Efinic might refer to |
|---|
| Efinaconazole (trade names Jublia and Clenafin) is a triazole antifungal. It is approved for use in Canada and the USA, JAPAN as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole acts as a 14α-demethylase inhibitor.In two clinical trials 17.8% and 15.2% of patients using efinaconazole were cured, compared to 3.3% and 5.5% of patients using a placebo.Efinaconazole is not especially effective, but it is currently the best topical treatment available, with cure rates two or three times better than the next best topical treatment, ciclopirox. It is considered a reasonable option for patients with mild cases, or patients who can not take oral treatment.In 2014, the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for Jublia, the "first topical triazole approved for the treatment of onychomycosis of the toenails." According to Valeant Pharmaceuticals International Inc CEO J. Michael Pearson they acquired Jublia through their purchase of Dow Pharmaceutical Sciences in 2008.In 2015 the cost of treatment with efinaconazole in the United States was said to be $2317 per nail. |